ArticleBreast cancer research and treatment2021

Cutaneous toxicities occurring during palbociclib (CDK4/6 inhibitor) and endocrine therapy in patients with advanced breast cancer: a single-centre experience.

Sumir Chawla et al.PubMed ↗Publisher ↗

No numbers read from the abstract.